Evidence map›Paper›PMID 35807276›Full record

ArticleMolecules (Basel, Switzerland)2022

Protective Effect of Resveratrol against Hexavalent Chromium-Induced Genotoxic Damage in Hsd:ICR Male Mice.

Tonancy Nicolás-Méndez, Sam Kacew, Alda Rocío Ortiz-Muñiz, Víctor Manuel Mendoza-Núñez, María Del Carmen García-Rodríguez

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Tonancy Nicolás-MéndezLaboratorio de Antimutagénesis, Anticarcinogénesis y Antiteratogénesis Ambiental, Facultad de Estudios Superiores-Zaragoza, Universidad Nacional Autónoma de México (UNAM), Mexico City 09230, Mexico.
Sam KacewMcLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, ON K2G 3G8, Canada.
Alda Rocío Ortiz-MuñizDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana (UAM), Mexico City 09310, Mexico.
Víctor Manuel Mendoza-NúñezUnidad de Investigación en Gerontología, Facultad de Estudios Superiores-Zaragoza, Universidad Nacional Autónoma de México (UNAM), Mexico City 09230, Mexico.ORCID 0000-0002-9137-3405
María Del Carmen García-RodríguezLaboratorio de Antimutagénesis, Anticarcinogénesis y Antiteratogénesis Ambiental, Facultad de Estudios Superiores-Zaragoza, Universidad Nacional Autónoma de México (UNAM), Mexico City 09230, Mexico.ORCID 0000-0001-5970-0835
Universidad Nacional Autónoma de México · MXUniversidad Autónoma Metropolitana · MXUniversity of Ottawa · CA

Funding

Consejo Nacional de Ciencia y Tecnología CONACyT, No. 703847Support Program for Research and Technological Innovation Projects, DGAPA-UNAM PAPIIT-IN224719
6 · The paper itself

Abstract

The aim of this study is to examine the ability of resveratrol to counteract hexavalent chromium [Cr(VI)]-induced genetic damage, as well as the possible pathways associated with this protection. Hsd:ICR male mice are divided into groups of the following five individuals each: (a) control 1, distilled water; (b) control 2, ethanol 30%; (c) resveratrol, 50 mg/kg by gavage; (d) CrO

Indexed as

ChromiumDNA Damage8-Hydroxy-2'-DeoxyguanosineAnimalsAntioxidantsMaleMiceMice, Inbred ICRResveratrol8-Hydroxy-2'-DeoxyguanosineAntioxidantsChromiumchromium hexavalent ionResveratrol8-hydroxydeoxyguanosine adduct repairantigenotoxicapoptosisendogenous antioxidant systemhexavalent chromiumresveratrol

Identifiers

PMID35807276
PMCPMC9268326
OpenAlexW4283370434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.